Amatuximab Terminated Phase 0 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Neoplasms, Ovarian / Pancreatic Ductal Carcinoma / Mesothelioma Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 0 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| https://clinicaltrials.gov/ct2/show/ | Amatuximab for High Mesothelin Cancers |